Latest News in the pharma Industry

Market News

Alvotech and DKSH extend biosimilar partnership in Asia

Alvotech and DKSH extend biosimilar partnership in Asia

22 Sep 2020

The companies will commercialize six new biosimilar candidates addressing multiple therapeutic areas.

Read more 
Europital launches as a science-driven full-service CRO

Europital launches as a science-driven full-service CRO

22 Sep 2020

Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries.

Read more 
Micreos initiates trial to evaluate world's first endolysin-drug as a therapy for atopic dermatitis

Micreos initiates trial to evaluate world's first endolysin-drug as a therapy for atopic dermatitis

22 Sep 2020

The targeted removal of one particular bacterial species from the skin microbiome, while preserving the beneficial ones, represents a new way to treat atopic dermatitis.

Read more 
T-knife and Catalent sign tech transfer and manufacturing agreement

T-knife and Catalent sign tech transfer and manufacturing agreement

21 Sep 2020

Catalent to manufacture clinical batches of T-knife's platform process for TCR-based cell therapy at its site in Gosselies, Belgium, for European trials in 2021.

Read more 
Metrics Contract Services begins $10M plant expansion

Metrics Contract Services begins $10M plant expansion

21 Sep 2020

Clients set to benefit immediately through "higher yields" and "improved potent handling".

Read more 
TESSA technology for robust and reproducible AAV manufacture at scale

TESSA technology for robust and reproducible AAV manufacture at scale

21 Sep 2020

Novel, plasmid-free manufacturing system reduces the cost of goods and improves AAV quality to enable development of safer gene therapies.

Read more 
Gilead Sciences agrees to buy Immunomedics in $21 billion deal

Gilead Sciences agrees to buy Immunomedics in $21 billion deal

16 Sep 2020

Acquisition will add Trodelvy, a first-in-class antibody-drug conjugate approved to treat breast cancer.

Read more 
Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate

Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate

15 Sep 2020

Humanigen's proprietary monoclonal antibody may prevent and treat cytokine storm, which is believed to trigger the acute respiratory distress syndrome in severe cases of COVID-19.

Read more 
Univercells Technologies introduces new upstream platform for virus manufacturing

Univercells Technologies introduces new upstream platform for virus manufacturing

15 Sep 2020

The NevoLine Upstream platform has been designed to address the needs of gene therapy and vaccine innovators and CDMOs for robust and cost-effective upstream viral vectors manufacturing.

Read more 
Mylan and development partner win significant EPO ruling related to Copaxone

Mylan and development partner win significant EPO ruling related to Copaxone

15 Sep 2020

Decision clears legal pathway to expand access for patients living with multiple sclerosis in markets across Europe.

Read more 
Evotec and Bioaster partner to build technology and innovation hub in Lyon

Evotec and Bioaster partner to build technology and innovation hub in Lyon

14 Sep 2020

Together, the companies will aim to put forward new research projects against infectious diseases and antimicrobial resistance, potentially creating new therapies and technologies.

Read more 
Biogen invests $250 million to eliminate its use of fossil fuels

Biogen invests $250 million to eliminate its use of fossil fuels

14 Sep 2020

After achieving carbon neutrality in 2014, Biogen further bolsters its action against climate change with the goal to become fossil fuel free by 2040.

Read more